此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Breathing Focused Yoga in Social Anxiety Disorder

2017年7月18日 更新者:Arun Ravindran、Centre for Addiction and Mental Health

A Randomized Controlled Trial of the Effectiveness of Breathing Focused Yoga (BFY) in Improving Symptoms of Social Anxiety Disorder

The goal of this study is to determine the safety and effectiveness of Breathing Focused Yoga (BFY) in improving symptoms of social anxiety disorder (SAD). Patients with SAD will be randomized to 8 weeks of yoga or 8 weeks of wait-list. Symptom severity and quality of life will be compared between the two groups before and after the 8 weeks.

研究概览

地位

完全的

详细说明

This is an exploratory 8-week study with a randomized controlled, parallel group design, and will be carried out in two phases: 1) 8-week treatment phase and 2) a 3-month follow-up phase.

60 patients meeting Diagnostic and Statistical Manual IV Text Revision, (DSM-IV-TR), diagnostic criteria for social anxiety disorder will be recruited. Patients who have provided written consent, have met study criteria, and are stabilized on pharmacotherapy will be enrolled into the study.

In the treatment phase, patients will be randomized, to one of two groups 1) Breathing Focused Yoga (BFY); or 2) wait-list group.

A sub-set of 15 drug- naïve patients and matched healthy controls will undergo functional magnetic resonance imaging (fMRI) scans before and after yoga treatment.

A blood sample for genetic analysis will be taken from all SAD patients, to investigate to presence of genes linked to SAD and t treatment response.

The primary aim of the study is to determine the safety and effectiveness of Breathing Focused Yoga (BFY) in improving symptoms of SAD.

There are two secondary aims:

  1. To enhance the limited research data on the effect of treatment on neural circuitry in SAD, the investigators will also conduct fMRI scans on SAD patients and matched healthy controls pre- and post-BFY intervention.
  2. As well, to add to the literature on the genetics of SAD, the investigators will validate the links between specific gene polymorphisms and SAD that are already identified in the literature, and evaluate if they predict treatment response following BFY intervention.

Primary Hypotheses

  1. Subjects with Social Anxiety Disorder will show significant improvement in symptoms after BFY, compared to the wait-list group.
  2. Improvement in quality of life scores will be significantly greater in the BFY group compared to the wait-list group.

Secondary Hypotheses

  1. At baseline, the fMRI indications of neural circuitry of SAD subjects will differ from that of healthy controls.
  2. After yoga treatment, the fMRI indications of neural circuitry of treatment responders in the SAD group will be similar to that of healthy controls.
  3. The presence of specific gene polymorphisms in SAD patients will predict treatment response.

研究类型

介入性

注册 (实际的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Ontario
      • Toronto、Ontario、加拿大、M6J 1H4
        • Centre for Addition and Mental Health

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Male or female patients aged 18-65 years
  2. Primary diagnosis of SAD, per the DSM-IV-TR (APA, 2000)
  3. LSAS score of ≥50
  4. Absence of serious medical illness
  5. Not on any psychotropic medications currently, or on stable medications for at least 8 weeks prior to starting treatment
  6. Short-acting benzodiazepines (e.g. lorazepam 1 mg prn) and sleep medications (e.g. zopiclone 7.5 mg prn) may be used, but not within 12 hours prior to a study visit

Exclusion Criteria:

  1. Current primary diagnosis of major depressive episode, mania or psychosis
  2. A score of ≥15 on the first 17 items of the HAM-D at Screening or Baseline
  3. Diagnosis of a substance abuse disorder within the prior 6 months
  4. Presence of medical or mental health conditions that would inhibit the patient's ability to participate in the study
  5. Currently receiving any structured formal psychotherapy (supportive therapy is allowed)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Yoga Treatment Group
BFY will be taught by a trained yoga instructor. Group sessions will be offered twice a week for 60 minutes each (i.e., a total of 2 hours per week), for 8 weeks.
The breathing focused yoga intervention is a manualized yoga protocol developed at CAMH by the Mood and Anxiety Disorders group, with yoga teacher, Ms. Tiffany Garfinkel, as the lead. BFY incorporates postures and meditation, but there is a special focus on controlled breathing at different rates, including Ujjaji or slow inhalation, exhalation and holding of breath; Bhastrika or Kapalabhati, two types of vigorous breathing with forced exhalation; and cyclical breathing or a repeated pattern of slow, moderate and fast breathing.
其他名称:
  • Breathing Focused Yoga
无干预:Waitlist Group
Waitlisted participants will receive BFY at the next available group after their waitlist period is completed

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Liebowitz 社交焦虑量表 (LSAS) 总分的变化
大体时间:研究终点的基线(第 8 周)
研究终点的基线(第 8 周)

次要结果测量

结果测量
大体时间
汉密尔顿抑郁量表 (HAM-D) 总分的变化
大体时间:研究终点的基线(第 8 周)
研究终点的基线(第 8 周)
Change in Clinical Global Impression Scale
大体时间:Baseline to study endpoint (Week 8)
Baseline to study endpoint (Week 8)
Change in Quality of Life Enjoyment and Satisfaction Scale (QLESQ) Total Score
大体时间:Baseline to study endpoint (Week 8)
Baseline to study endpoint (Week 8)
Change in Quick Inventory of Depressive Symptomatology (QIDS) Total Score
大体时间:Baseline to study endpoint (Week 8)
Baseline to study endpoint (Week 8)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2012年1月1日

初级完成 (实际的)

2017年1月1日

研究完成 (实际的)

2017年1月30日

研究注册日期

首次提交

2014年10月7日

首先提交符合 QC 标准的

2014年10月14日

首次发布 (估计)

2014年10月17日

研究记录更新

最后更新发布 (实际的)

2017年7月19日

上次提交的符合 QC 标准的更新

2017年7月18日

最后验证

2016年9月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • 150/2011

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅